Kei Sawara

670 total citations
38 papers, 486 citations indexed

About

Kei Sawara is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kei Sawara has authored 38 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 25 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Kei Sawara's work include Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). Kei Sawara is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). Kei Sawara collaborates with scholars based in Japan and Canada. Kei Sawara's co-authors include Kazuyuki Suzuki, Yasuhiro Takikawa, Hidekatsu Kuroda, Akinobu Kato, Ryujin Endo, Yasuhiro Miyamoto, Kazuhiro Kasai, Takayoshi Oikawa, Yasuhiro Takikawa and Keisuke Kakisaka and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and World Journal of Gastroenterology.

In The Last Decade

Kei Sawara

35 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kei Sawara Japan 14 316 254 118 65 47 38 486
Ryujin Endo Japan 15 363 1.1× 306 1.2× 110 0.9× 55 0.8× 26 0.6× 28 592
Maria Grazia Lucà Italy 10 186 0.6× 160 0.6× 128 1.1× 126 1.9× 27 0.6× 23 506
I. Bilbao Spain 7 99 0.3× 190 0.7× 101 0.9× 123 1.9× 35 0.7× 13 425
Kuei‐Chuan Lee Taiwan 17 277 0.9× 325 1.3× 108 0.9× 49 0.8× 42 0.9× 35 605
John H. Helzberg United States 13 205 0.6× 221 0.9× 200 1.7× 45 0.7× 63 1.3× 32 579
Rumi Mifuji‐Moroka Japan 13 142 0.4× 184 0.7× 52 0.4× 202 3.1× 14 0.3× 20 439
Xiaojing Cao China 13 133 0.4× 88 0.3× 160 1.4× 19 0.3× 78 1.7× 44 464
Sabrina Alves Fernandes Brazil 13 210 0.7× 302 1.2× 61 0.5× 232 3.6× 29 0.6× 42 566
Le Sun China 12 73 0.2× 147 0.6× 88 0.7× 92 1.4× 64 1.4× 35 505
R H Lu Taiwan 9 226 0.7× 197 0.8× 100 0.8× 37 0.6× 24 0.5× 16 368

Countries citing papers authored by Kei Sawara

Since Specialization
Citations

This map shows the geographic impact of Kei Sawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Sawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Sawara more than expected).

Fields of papers citing papers by Kei Sawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Sawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Sawara. The network helps show where Kei Sawara may publish in the future.

Co-authorship network of co-authors of Kei Sawara

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Sawara. A scholar is included among the top collaborators of Kei Sawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Sawara. Kei Sawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakisaka, Keisuke, Takuya Watanabe, Hiroaki Abe, et al.. (2024). Low liver reserve is a risk factor for acute pancreatitis in patients with acute liver failure. Hepatology Research. 55(1). 130–137. 1 indexed citations
2.
Kuroda, Hidekatsu, Tamami Abe, Keisuke Kakisaka, et al.. (2024). Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment. Drugs - Real World Outcomes. 11(4). 701–710. 2 indexed citations
3.
Yoshida, Yuichi, et al.. (2022). Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection. Health Science Reports. 5(1). e458–e458. 6 indexed citations
4.
Yoshida, Yuichi, et al.. (2021). A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination. International Journal of General Medicine. Volume 14. 8935–8943. 5 indexed citations
5.
Abe, Tamami, Yudai Fujiwara, Takuya Okamoto, et al.. (2019). Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World Journal of Gastroenterology. 25(19). 2365–2372. 24 indexed citations
6.
Endo, Kei, Hidekatsu Kuroda, Keisuke Kakisaka, et al.. (2017). Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages. Internal Medicine. 57(9). 1247–1251. 4 indexed citations
8.
Katayama, Kazuhiro, Masanori Saito, Takumi Kawaguchi, et al.. (2014). Effect of zinc on liver cirrhosis with hyperammonemia: A preliminary randomized, placebo-controlled double-blind trial. Nutrition. 30(11-12). 1409–1414. 61 indexed citations
9.
Kuroda, Hidekatsu, Keisuke Kakisaka, Takayoshi Oikawa, et al.. (2014). Liver stiffness measured by acoustic radiation force impulse elastography reflects the severity of liver damage and prognosis in patients with acute liver failure. Hepatology Research. 45(5). 571–577. 19 indexed citations
10.
Suzuki, Kazuyuki, Keisuke Kakisaka, Kei Endo, et al.. (2013). Serum free fatty acid concentration as a surrogate marker for serum carnitine status in patients with liver cirrhosis. Kanzo. 54(11). 796–797. 1 indexed citations
11.
Kuroda, Hidekatsu, Yasuhiro Takikawa, Keisuke Kakisaka, et al.. (2011). Serial changes of liver stiffness measured by acoustic radiation force impulse imaging in acute liver failure: A case report. Journal of Clinical Ultrasound. 40(2). 99–104. 11 indexed citations
12.
Kasai, Kazuhiro, et al.. (2011). Conservative treatment of an aortoesophagial fistula after endovascular stent grafting for a thoracic aortic aneurysm: Case report. Medical Science Monitor. 17(4). CS39–CS42. 7 indexed citations
14.
Kasai, Kazuhiro, Kei Sawara, Yasuhiro Miyamoto, et al.. (2010). Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma. International Journal of Clinical Oncology. 16(3). 221–229. 13 indexed citations
15.
Kuroda, Hidekatsu, Yasuhiro Miyamoto, Kei Sawara, et al.. (2010). Effects of branched‐chain amino acid‐enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: A one‐year prospective trial. Journal of Gastroenterology and Hepatology. 25(9). 1550–1555. 46 indexed citations
16.
Kuroda, Hidekatsu, Kazuhiro Kasai, Keisuke Kakisaka, et al.. (2010). Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma. Hepatology Research. 40(5). 550–554. 16 indexed citations
17.
Sawara, Kei, Paul Desjardins, Nicolas Chatauret, et al.. (2009). Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure. Neurochemistry International. 55(1-3). 119–123. 23 indexed citations
18.
Kato, Akinobu, Yuki Watanabe, Kei Sawara, & Kazuyuki Suzuki. (2008). Diagnosis of sub‐clinical hepatic encephalopathy by Neuropsychological Tests (NP‐tests). Hepatology Research. 38(s1). S122–7. 12 indexed citations
19.
Takikawa, Yasuhiro, Yuki Watanabe, & Kei Sawara. (2005). Successful perioperative management with activated protein C preparation for a surgical patient with gastric cancer who had multifocal deep venous thrombosis due to congenital protein C deficiency. 57(1). 63–70.
20.
Sawara, Kei. (2004). Brain glutamine and glutamate levels in patients with liver cirrhosis: assessed by 3.0-T MRS. Hepatology Research. 30(1). 18–23. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026